Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
{{output}}
Lung cancer is the leading cause of cancer deaths worldwide. Targeting the epidermal growth factor receptor (EGFR) has played a central role in advancing non-small-cell lung cancer (NSCLC) research, treatment, and patient outcome over the last few years. Erlot... ...
